These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1438000)
1. Vaginal absorption of insulin in the rat: effect of penetration enhancers on insulin uptake and mucosal histology. Richardson JL; Illum L; Thomas NW Pharm Res; 1992 Jul; 9(7):878-83. PubMed ID: 1438000 [TBL] [Abstract][Full Text] [Related]
2. Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and rats. Deurloo MJ; Hermens WA; Romeyn SG; Verhoef JC; Merkus FW Pharm Res; 1989 Oct; 6(10):853-6. PubMed ID: 2692018 [TBL] [Abstract][Full Text] [Related]
3. Effects of absorption enhancers on human nasal tissue ciliary movement in vitro. Hermens WA; Hooymans PM; Verhoef JC; Merkus FW Pharm Res; 1990 Feb; 7(2):144-6. PubMed ID: 2408030 [TBL] [Abstract][Full Text] [Related]
4. Nasal absorption in the rat. III. Effect of lysophospholipids on insulin absorption and nasal histology. Chandler SG; Thomas NW; Illum L Pharm Res; 1994 Nov; 11(11):1623-30. PubMed ID: 7870681 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of enhancers to increase nasal absorption using Ussing chamber technique. Hosoya K; Kubo H; Natsume H; Sugibayashi K; Morimoto Y Biol Pharm Bull; 1994 Feb; 17(2):316-22. PubMed ID: 7515747 [TBL] [Abstract][Full Text] [Related]
6. Intranasal bioavailability of insulin powder formulations: effect of permeation enhancer-to-protein ratio. Lee WA; Narog BA; Patapoff TW; Wang YJ J Pharm Sci; 1991 Aug; 80(8):725-9. PubMed ID: 1791529 [TBL] [Abstract][Full Text] [Related]
7. Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers. Marttin E; Verhoef JC; Cullander C; Romeijn SG; Nagelkerke JF; Merkus FW Pharm Res; 1997 May; 14(5):631-7. PubMed ID: 9165535 [TBL] [Abstract][Full Text] [Related]
8. Absorption enhancement of rectally infused insulin by sodium tauro-24,25-dihydrofusidate (STDHF) in rats. van Hoogdalem EJ; Heijligers-Feijen CD; Verhoef JC; de Boer AG; Breimer DD Pharm Res; 1990 Feb; 7(2):180-3. PubMed ID: 2106676 [TBL] [Abstract][Full Text] [Related]
9. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside. Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081 [TBL] [Abstract][Full Text] [Related]
10. Absorption enhancement of intrapulmonary administered insulin by various absorption enhancers and protease inhibitors in rats. Yamamoto A; Umemori S; Muranishi S J Pharm Pharmacol; 1994 Jan; 46(1):14-8. PubMed ID: 7515417 [TBL] [Abstract][Full Text] [Related]
11. Sublingual delivery of insulin: effects of enhancers on the mucosal lipid fluidity and protein conformation, transport, and in vivo hypoglycemic activity. Cui CY; Lu WL; Xiao L; Zhang SQ; Huang YB; Li SL; Zhang RJ; Wang GL; Zhang X; Zhang Q Biol Pharm Bull; 2005 Dec; 28(12):2279-88. PubMed ID: 16327166 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary absorption of insulin mediated by tetradecyl-beta-maltoside and dimethyl-beta-cyclodextrin. Hussain A; Yang T; Zaghloul AA; Ahsan F Pharm Res; 2003 Oct; 20(10):1551-7. PubMed ID: 14620506 [TBL] [Abstract][Full Text] [Related]
13. Effect of cell-penetrating peptides on the nasal absorption of insulin. Khafagy el-S; Morishita M; Isowa K; Imai J; Takayama K J Control Release; 2009 Jan; 133(2):103-8. PubMed ID: 18930084 [TBL] [Abstract][Full Text] [Related]
14. Alternative delivery of insulin via eye drops. Xuan B; McClellan DA; Moore R; Chiou GC Diabetes Technol Ther; 2005 Oct; 7(5):695-8. PubMed ID: 16241870 [TBL] [Abstract][Full Text] [Related]
15. Hypoglycaemia associated to vaginal insulin placement in rats. Ortega-Corona BG; GarcĂa-Pineda J; Parra A; Gallegos AJ Arch Invest Med (Mex); 1989; 20(3):239-42. PubMed ID: 2699227 [TBL] [Abstract][Full Text] [Related]
16. Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep. Longenecker JP; Moses AC; Flier JS; Silver RD; Carey MC; Dubovi EJ J Pharm Sci; 1987 May; 76(5):351-5. PubMed ID: 3309255 [TBL] [Abstract][Full Text] [Related]
17. Effects of intravaginal dehydroepiandrosterone on vaginal histomorphology, sex steroid receptor expression and cell proliferation in the rat. Berger L; El-Alfy M; Labrie F J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):67-80. PubMed ID: 18242978 [TBL] [Abstract][Full Text] [Related]
18. Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy. Hurni MA; Noach AB; Blom-Roosemalen MC; de Boer AG; Nagelkerke JF; Breimer DD J Pharmacol Exp Ther; 1993 Nov; 267(2):942-50. PubMed ID: 7504101 [TBL] [Abstract][Full Text] [Related]
19. Improvement of systemic absorption of insulin through eyes with absorption enhancers. Chiou GC; Chuang CY J Pharm Sci; 1989 Oct; 78(10):815-8. PubMed ID: 2689632 [TBL] [Abstract][Full Text] [Related]
20. Promoting effects of chemical permeation enhancers on insulin permeation across TR146 cell model of buccal epithelium in vitro. Xue XY; Zhou Y; Chen YY; Meng JR; Jia M; Hou Z; Bai H; Mao XG; Luo XX Drug Chem Toxicol; 2012 Apr; 35(2):199-207. PubMed ID: 21848502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]